• Bradford Protein Assay Kit: Protocol and QC

  2026-08-24

  The Bradford Protein Assay Kit (SKU K4103) provides a fast protein concentration measurement using Coomassie Brilliant Blue G-250 and a BSA calibration series. It is suited to routine enzyme, purification, and molecular biology workflows, but high-detergent samples and protein concentrations outside the validated range require alternative preparation or assay strategies.

• Curcumin, PBDE-47, and NETs: Nrf2-ROS Mechanism

  2026-08-24

  The reference study shows that the persistent flame retardant PBDE-47 can stimulate neutrophil extracellular trap formation through oxidative stress, while curcumin suppresses this response through an Nrf2-associated ROS mechanism. Its combined imaging, fluorescence-based quantification, and pathway-intervention strategy provides a useful framework for studying pollutant-driven innate immune injury.

• Gentamycin Sulfate: Mechanism & Research Uses

  2026-08-23

  Gentamycin Sulfate is an aminoglycoside antibiotic that disrupts bacterial translation through the 30S decoding center. Its defined product specifications and relevance to carbapenemase-associated gentamicin resistance make it useful for bacterial protein synthesis research, ribosome function analysis, and resistance-model design.

• NLRP3 Astrocyte Remodeling in Morphine Tolerance

  2026-08-22

  Yuan et al. connect NLRP3 inflammasome activity with a shift toward the neurotoxic A1 astrocyte phenotype during morphine tolerance. Their pharmacological model shows that MCC950 slows tolerance development and normalizes inflammatory and astrocyte-state markers, while also highlighting the need for more direct causal and translational testing.

• ONX-0914 (PR-957) Workflow for Immune Assays

  2026-08-22

  ONX-0914 (PR-957) enables selective LMP7 inhibition for cytokine, autoimmune, and mechanistic antiviral assays. This practical guide connects compound handling with Nef–STAT1 research while showing how controls distinguish immunoproteasome biology from general proteasome or solvent effects.

• Pyridostatin TFA: G-Quadruplex Research Workflows

  2026-08-21

  Pyridostatin TFA gives researchers a practical chemical handle for stabilizing G-quadruplexes in telomere, cancer, and DNA secondary structure studies. This guide connects dose-controlled cell assays with emerging G-quadruplex–TDP-43 research, emphasizing controls, workflow design, and troubleshooting rather than simple compound description.

• Ibrexafungerp Against Fluconazole-Resistant Candida auris

  2026-08-20

  This study evaluated the oral triterpenoid antifungal ibrexafungerp, also known as MK 3118, against fluconazole-resistant Candida auris using both broth microdilution and a delayed-treatment murine model of invasive candidiasis. Consistent in vitro activity and improved survival and kidney fungal burdens in treated mice support further investigation of ibrexafungerp for difficult-to-treat C. auris infections, while the model also defines important translational limitations.

• Ashwagandha Digestion: LC–MS/MS Metabolomics

  2026-08-20

  This study integrates simulated gastrointestinal digestion, LC–MS/MS profiling, untargeted metabolomics, and molecular networking to characterize how Withania somnifera leaf and root extracts change before absorption. Its compound-specific findings show that withaferin A and withanoside IV are labile under the tested conditions, whereas withanolide A is comparatively stable, highlighting the importance of digestive transformation in botanical bioavailability studies.

• Ibrexafungerp Activity at Vaginal pH: Study Insights

  2026-08-19

  The Sobel et al. study tested ibrexafungerp, also known as MK 3118, against 187 clinical Candida isolates under neutral and acidic conditions relevant to vulvovaginal candidiasis. Its central finding was that activity was preserved at pH 4.5, including against fluconazole-resistant and non-albicans Candida isolates, supporting further translational evaluation while remaining an in vitro result.

• Drug Response Metrics in Cancer In Vitro

  2026-08-19

  Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating growth inhibition from cell killing, helping researchers interpret timing, mechanism, and assay results more accurately.

• Dabigatran for Thromboembolic Disorders: Evidence Review

  2026-08-18

  The 2015 review by Enriquez and colleagues examined dabigatran as the first widely introduced non-vitamin K oral anticoagulant, emphasizing its direct thrombin inhibition, predictable pharmacokinetics, and clinical evidence across atrial fibrillation, venous thromboembolism, and orthopedic prophylaxis. Its practical contribution is a balanced framework: dabigatran reduces dependence on routine coagulation monitoring, but renal clearance, P-glycoprotein interactions, and bleeding management remain central to appropriate use.

• Acetylspiramycin: From Biosynthesis to Assay Design

  2026-08-18

  Acetylspiramycin, also known as Spiramycin B, is a macrolide antibiotic whose value extends beyond routine susceptibility testing. This article connects ribosomal pharmacology, biosynthetic component control, antimicrobial resistance research, and immune-focused assay design.

• Dimethyloxalylglycine (DMOG) Protocol Guide

  2026-08-17

  Dimethyloxalylglycine (DMOG) provides a practical pharmacologic approach for hypoxia-inducible factor stabilization and controlled study of oxygen-sensing responses. It is intended for defined in vitro and preclinical research workflows, not for diagnosis, treatment, or extrapolation beyond the tested model.

• NU7441 (KU-57788) DNA-PK Workflow Guide

  2026-08-17

  NU7441 (KU-57788) provides a selective way to interrogate DNA-PK-dependent repair, drug sensitization, and cell-cycle responses. This workflow-focused guide connects oncology research with DNA damage assays while emphasizing controls, formulation, and troubleshooting.

• HyperFusion high-fidelity DNA polymerase Workflow

  2026-08-16

  Build more reliable PCR workflows for C. elegans neurodegeneration studies, from allele verification and construct cloning to sequencing-ready amplicons. HyperFusion™ combines proofreading accuracy, speed, blunt-end products, and inhibitor tolerance for difficult or GC-rich templates.

8444 records 1/563 page Next 12345 下5页 Last page